Berney Discusses Increasing Venture Capital Investment in China’s Biomedical Sector
Partner Kurt Berney
was quoted in the 21st Century Business Herald
article, “Lilly Asia Ventures Begins Direct Investment in China-Based Pharmaceutical Enterprises.” The article discusses the increasing number of venture capital funds in China’s biomedical sector. In the article, Berney states that a few years ago, foreign VC funds were only waiting to see their chances in China’s biotech pharmaceutical markets; but now, the situation is undergoing some changes. He goes on to say that an increasing number of biotech pharmaceutical companies are getting venture investments.
November 14, 2007